Tracking influenza in its first battleground: The nose – Boston Children’s Discoveries

The answer to curbing influenza could be right under our noses or, more accurately, inside them. New research maps happenings in the nose during the course of influenza in exquisite detail, and could potentially lead to new targets and more effective nasal flu vaccines.

The nose is often the gateway to respiratory infections, where viruses first set up shop and start replicating. But strangely, the immune response in the nose has been relatively unexplored.

The National Heart, Lung, and Blood Institute has traditionally covered the lung through the trachea, and another NIH institute funds research for craniofacial and dental disorders, says Boston Childrens Hospital researcher Jos Ordovs-Montas, PhD. Where does the nose fit?

Ordovs-Montas first took on this underfunded body part during the COVID-19 pandemic. His lab showed that people who developed severe COVID-19 had weak antiviral responses in the nose and throat.In new work led by Samuel Kazer, PhD, the team analyzed what happened in the noses of mice during flu infection.

Unlike the COVID study, which analyzed patients nasal swabs at a single point in time, the new study tracked events throughout the nose, including parts not reachable with a nasal swab, throughout a flu episode. To better understand immune memory, the researchers resampled the mice after a second influenza infection. They published their findings last week in the journal Immunity.

Over the course of infection, the researchers sequenced the RNA of thousands of individual cells in the nasal mucosa (the tissue lining the nasal cavity) in all, more than 150,000 readouts over two weeks. This created a dynamic atlas, cataloguing what kinds of cells were there and how each was responding. The team identified 127 cell types and subtypes, including the epithelial cells that line the mucosa, multiple types of immune cells, cells making up connective tissue, and even neurons that facilitate smell.

We saw lots of interesting cellular diversity within this micro-anatomy, says Ordovs-Montas. When we sample people with swabs, we just scrape the surface. Sam was able to look at the full tissue.

Different cells came and went during influenza infection. For example, neutrophils (first-responder immune cells) appeared almost immediately, but left once the virus was cleared. Tissue-resident memory T cells (TRM cells), which maintain memory of an infection in the tissue, showed up around day 14. They remained in the nose thereafter, right through the second bout of flu, as did plasmablasts, which matured into antibody-producing plasma cells.

One previously undescribed group of cells took the stage one to two weeks after the start of infection. Dubbed Krt13+ nasal immune-interacting floor epithelial cells (KNIIFE cells), they run along the bottom of the nasal cavity, just above the palate of the mouth. Kazers expertise at the intersection of biology and computational science made their discovery possible, says Ordovs-Montas.

We almost threw those cells out because they looked so weird, he adds.

These cells may be key to the more rapid, coordinated immune responses the team saw during the second influenza infection.

KNIIFE cells express many genes associated with immune function that were not used to seeing in epithelial cells, Kazer elaborates. They expand after the virus is cleared, in the same anatomical location as the TRM cells. We think they may help maintain the memory of an infection.

The team is now further exploring the role of KNIIFE cells and plans to correlate the findings from mice with nasal-swab data from people with influenza and from children seen at Boston Childrens Hospital with other viral infections. Kazer hopes their work will one day lead to a long-lasting nasal vaccine that could limit the spread of disease beyond the nose by helping the nose remember the flu virus.

Memory can take place in many types of cells, he says. Understanding how memory looks in a barrier tissue like the nasal mucosa is some basic biology were trying to get at.

For regular science updates from Boston Childrens, subscribe to our research newsletter.

The bodys first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A ...

Inflammatory bowel disease (IBD), causing devastating abdominal pain, persistent diarrhea, and rectal bleeding, is hard to control with current treatments. ...

While conventional flu vaccines are designed to anticipate the influenza strains projected to dominate in the next flu season, they...

As we age our immune systems start to flag, leaving us more susceptible to cancer and infections and less responsive ...

Link:

Tracking influenza in its first battleground: The nose - Boston Children's Discoveries